ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 2604

$490K Total Retail Price of All Prescriptions

Rank: 221 out of 2604

467 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,156 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 467 334 1 2
OMEPRAZOLE 447 287 2 5
LEVOTHYROXINE SODIUM 340 213 3 4
LISINOPRIL 332 245 4 3
HYDROCODONE-ACETAMINOPHEN 305 205 S3 5 1
FUROSEMIDE 280 210 6 8
METOPROLOL TARTRATE 228 182 7 9
POTASSIUM CHLORIDE 217 180 8 16
AMLODIPINE BESYLATE 211 171 9 6
WARFARIN SODIUM 177 151 10 13
BUMETANIDE 173 143 11 70
METFORMIN HCL 164 93 12 7
GABAPENTIN 161 73 13 12
DONEPEZIL HCL 136 116 14 28
ALENDRONATE SODIUM 134 91 15 29
MORPHINE SULFATE ER 132 41 S2 16 58
NAMENDA 128 124 17 37
TRAMADOL HCL 117 78 18 15
CEPHALEXIN 114 78 19 74
CARVEDILOL 111 82 20 26
LANTUS 109 69 21 40
RANITIDINE HCL 104 60 22 25
TRAZODONE HCL 102 72 23 46
KLOR-CON M20 99 81 24 86
SERTRALINE HCL 95 73 25 23
POLYETHYLENE GLYCOL 3350 94 69 26 42
ATORVASTATIN CALCIUM 91 77 27 19
BACLOFEN 90 31 28 101
ISOSORBIDE MONONITRATE ER 89 82 29 38
PROAIR HFA 89 30 29 27
CITALOPRAM HBR 89 59 29 18
TAMSULOSIN HCL 88 73 32 30
JANTOVEN 87 74 33 118
OXYBUTYNIN CHLORIDE 84 63 34 92
SPIRONOLACTONE 82 64 35 78
PREDNISONE 79 70 36 34
FENTANYL 76 76 S2 37 48
LOSARTAN POTASSIUM 75 74 38 20
HYDROCHLOROTHIAZIDE 69 54 39 10
CIPROFLOXACIN HCL 69 53 39 59
OXYBUTYNIN CHLORIDE ER 67 47 41 110
NAPROXEN 64 26 42 76
FLUTICASONE PROPIONATE 64 39 42 31
MIRTAZAPINE 60 52 44 52
NOVOLOG 59 44 45 89
PRAVASTATIN SODIUM 58 45 46 14
IBUPROFEN 54 11 47 32
LEVETIRACETAM 54 24 47 96
FLUOXETINE HCL 54 47 47 49
INSULIN SYRINGE 53 33 50 109
GLIMEPIRIDE 53 38 50 57
DILTIAZEM 24HR CD 52 45 52 124
NEXIUM 52 29 52 53
METOPROLOL SUCCINATE 51 48 54 17
ZOLPIDEM TARTRATE 50 20 55 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.